Gene: HPGD
Official Full Name: 15-hydroxyprostaglandin dehydrogenaseprovided by HGNC
Gene Summary: This gene encodes a member of the short-chain nonmetalloenzyme alcohol dehydrogenase protein family. The encoded enzyme is responsible for the metabolism of prostaglandins, which function in a variety of physiologic and cellular processes such as inflammation. Mutations in this gene result in primary autosomal recessive hypertrophic osteoarthropathy and cranioosteoarthropathy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37211 | HPGD Knockout cell line (HeLa) | Human | HPGD | 1:3~1:6 | Negative | Online Inquiry |
KO37212 | HPGD Knockout cell line (HEK293) | Human | HPGD | 1:3~1:6 | Negative | Online Inquiry |
KO37213 | HPGD Knockout cell line (A549) | Human | HPGD | 1:3~1:4 | Negative | Online Inquiry |
HPGD Gene Knockout Cell Lines are specialized cellular models specifically engineered to lack the expression of the hydroxyprostaglandin dehydrogenase (HPGD) gene. This gene encodes an enzyme critical for the metabolism of prostaglandins, mediators that play key roles in various physiological processes such as inflammation, pain, and vascular progression. The knockout of HPGD results in altered levels and actions of prostaglandins, allowing researchers to investigate their biological functions without the confounding effects of this specific enzymatic activity.
The primary function of HPGD Gene Knockout Cell Lines lies in their ability to facilitate studies on prostaglandin signaling pathways and their implications in diseases like cancer, cardiovascular disorders, and metabolic syndromes. These models enable precision experimentation, allowing researchers to elucidate the contributions of HPGD-lacking cells in pathological mechanisms, study drug interactions, or evaluate potential therapeutic targets.
The scientific importance of these cell lines cannot be overstated; their application spans basic biomedical research, drug discovery, and therapeutic development. By providing insights into prostaglandin regulation, HPGD Gene Knockout Cell Lines offer a unique avenue for understanding disease etiology and therapeutic response.
Compared to traditional cell models, these knockout lines present several advantages: the specifically targeted gene disruption leads to more rigorous data regarding HPGD-related pathways, while minimizing background noise from non-targeted cellular mechanisms. Moreover, these cell lines are reproducibly produced under stringent quality controls, ensuring consistent performance across experiments.
For researchers and clinicians seeking to deepen their understanding of prostaglandin-related processes in health and disease, HPGD Gene Knockout Cell Lines represent an invaluable tool. They offer unparalleled specificity, enabling actionable insights into cellular responses and potential therapeutic interventions.
Our company prides itself on its expertise in genetic engineering and cell line development, committed to providing high-quality biological products that empower researchers in their quest for scientific knowledge and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.